Circadian clock genes as promising therapeutic targets for bone loss - 08/12/22


Abstract |
The circadian clock regulates many key physiological processes such as the sleep–wake cycle, hormone release, cardiovascular health, glucose metabolism and body temperature. Recent evidence has suggested a critical role of the circadian system in controlling bone metabolism. Here we review the connection between bone metabolism and the biological clock, and the roles of these mechanisms in bone loss. We also analyze the regulatory effects of clock-related genes on signaling pathways and transcription factors in osteoblasts and osteoclasts. Additionally, osteocytes and endothelial cells (ECs) regulated by the circadian clock are also discussed in our review. Furthermore, we also summarize the regulation of circadian clock genes by some novel modulators, which provides us with a new insight into a potential strategy to prevent and treat bone diseases such as osteoporosis by targeting circadian genes.
Le texte complet de cet article est disponible en PDF.Graphical Abstract |
Abbreviations : ECs, SCN, TTFLs, BMAL1, CLOCK, PER, CRY, REV-ERBs, RORs, bHLH-PAS, PTMs, CK1, RANKL, OPG, CTSK, P1NP, SMH, BMSCs, BMPs, SMAD1, TCF/LEF, Runx2, OSX, OPN, OCN, ALP, PPARγ, M-CSF, DL cycle, OA, GC, CHIP, ADX, CORT, BMMs, P1NP, PDLCs, CCL2, T2DM, FGF-23, BTMs, Sost, DKK1, PTH, HU, VEGF, HIF, FABP4
Keywords : Bone, Circadian clock gene, Osteoporosis, Circadian rhythm, biological clock
Plan
Vol 157
Article 114019- janvier 2023 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?